4//SEC Filing
Koppikar Utpal 4
Accession 0001567619-22-012667
CIK 0001604464other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:20 PM ET
Size
5.0 KB
Accession
0001567619-22-012667
Insider Transaction Report
Form 4
Koppikar Utpal
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-06-08$5.63/sh−5,853$32,952→ 203,529 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
- [F2]Includes 1,790 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2022.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001742696
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:20 PM ET
- Size
- 5.0 KB